Morgan Stanley
Hong Kong | Sunday, 12 October 2008

Merck Articles

View All Articles About 'Merck'
1. Merck's Osteoporosis drug enters Phase III trial
Merck & Co. reported a Phase III trial which studies odanacatib for the treatment of osteoporosis in postmenopausal woman is underway which will include tests for breast and prostate cancer.
30 May 2008
2. Merck to Pay $58 Mil to Settle Vioxx Advertising Case
Merck & Co. said on Tuesday it agreed to pay $58 million to settle allegations that its ads for the once-popular painkiller Vioxx deceptively played down the health risks in 29 states, including the District of Columbia.
21 May 2008
3. Merck Cuts 1,200 sales jobs amid Non Approval of Cordaptive
The number of cuts represents 15 percent of Merck's US sales force of 8,500 at the beginning of 2007. Affected employees will be notified by the end of May and they will leave by the end of July with
06 May 2008
4. Merck, Schering-Plough sink on Vytorin
Shares of Merck & Co. and Schering-Plough Corp. fell to record lows Monday, as analysts warned new clinical data...
01 Apr 2008
5. FDA investigates suicide with Merck drug
The Food and Drug Administration said Thursday it is investigating a possible link between Merck's best-selling...
28 Mar 2008
6. Merck to Outsource Some Work to India
Pharmaceutical giant Merck & Co has agreed to outsource some of its drug research work to India's Advinus Therapeutics in a deal.
16 Nov 2006
7. Merck to buy biotech firm for $1.1B
Pharmaceutical company Merck & Co. said Monday it agreed to pay an eye-popping $1.1 billion to buy Sirna Therapeutics Inc.......
31 Oct 2006
8. Merck, Schering-Plough shares climb
Drugmakers Merck and Schering-Plough, partners on their crucial cholesterol drugs, both saw their shares climb Friday after posting......
21 Oct 2006
9. Merck Buys Major Stake in Biotech Firm
German drug maker Merck KGaA said Thursday it agreed to buy a majority stake in Swiss rival Serono SA in a transaction that values the business at 16.6 billion Swiss francs ($13.3 billion).
21 Sep 2006
10. Merck Suffers 2 Setbacks Over Vioxx
Merck & Co. got slammed with two Vioxx trial setbacks on Thursday, calling into question the drug maker's strategy of taking on litigation over the withdrawn painkiller one case at a time.
18 Aug 2006
[1] [2]
advertisement